Home
Conditions
Carcinoma, Non-Small-Cell Lung

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,689 public trials 1,036 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial

NCT06363734

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Department of Thoracic Medical Oncology, Tianjin Medical University Cancer Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Development and Analysis of a Stool Bank for Cancer Patients

NCT04291755

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Colorectal, +17 more
Locations: Compassionate Care Research Group, Inc. Fountain Valley, California, United States

Bond and Steele Clinic, P.A. Winter Haven, Florida, United States

View Trial Details

Recruiting

A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer

NCT06225804

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Precision NextGen Oncology Beverly Hills, California, United States

Anhui Chest Hospital Hefei, Anhui, China

Fujian Cancer Hospital Fuzhou, Fujian, China

The first Affiliated Hospital of Xi'an Jiaotong University Xi'an, Harbin, China

View all 14 locations

View Trial Details

Recruiting

Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NCT06020430

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Hubei Cancer Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

A Prospective Cohort Study to Evaluate Molecular pRognostic Factors and Resistance Mechanisms to Osimertinib in Adjuvant Treatment of Completely Resected pIB-IIIA Non-small Cell Lung Carcinoma With Common EGFR Mutations (L858R and Del19)

NCT06053099

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Angers - CHU Angers, France

Bayonne - CH Bayonne, France

Boulogne - Ambroise Paré Boulogne, France

Lyon - URCOT Bron, France

View all 36 locations

View Trial Details

Recruiting

A Randomised Open-label Phase III Trial of REduced Frequency Pembrolizumab immuNothErapy for First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

NCT05085028

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Royal Bournemouth Hospital Bournemouth, United Kingdom

Royal Sussex County Hospital Brighton, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

Queen's Hospital Burton-on-Trent, United Kingdom

View all 37 locations

View Trial Details

Recruiting

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC

NCT05332925

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: The University of Kansas Cancer Center (KUCC) Fairway, Kansas, United States

The University of Kansas Cancer Center, Westwood Campus Kansas City, Kansas, United States

View Trial Details

Recruiting

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

NCT05377658

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Recruiting

Exploration on the Value of MRD Based on ctDNA Detection in Predicting Recurrence of Resected Non-small Cell Lung Cancer

NCT05965024

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers

NCT06255197

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
Locations: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China

View Trial Details

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung trial results

Related conditions